Smartlab Europe

Press Releases

P-Logi to Lead Pharmaceutical Enterprises into a New Era of Developed Logistics

Modern pharmaceutical logistics is stepping into the fast lane of transformation, alongside with rebuild of the pharmaceutical value chain and improvement of industrial concentration. P-Logi 2016, themed as "new era of pharmaceutical logistics",will centrally showcase the latest technologies and...

NEX China 2016 to Set Sail by the “Healthy and Natural” Wind

NEX China 2016, hosted by UBM EMEA and China Chamber of Commerce of Medicines &Health Products Importers & Exporters and co-organized by UBM Sinoexpo, will be held on 21 – 23rd June 2016 at Hall E2 in Shanghai New...

Grasp the opportunity at Emerging Markets for High Growth of Life Science and Chemical Instrumentation

The global life science and chemical instrumentation market will reach USD48.84 billion by 2019, with the compound average growth rate of 6.9%. Geographically, North America is the global largest life science and chemical instrumentation market, however, developing regions such...

ICSE China 2016 – A gala event for pharma CRO & CMO industry

ICSE China 2016, hosted by UBM EMEA and China Chamber of Commerce of Medicines & Health Products Importers & Exporters and co-organized by UBM Sinoexpo,will be held on 21 – 23rd June at Hall E2 in Shanghai New International...

Mersana Therapeutics and Takeda Expand Partnership to Advance Development of Fleximer Antibody-Drug

Mersana Therapeutics and Takeda Pharmaceutical Company Limited announced that they have entered a new strategic partnership granting Takeda rights to Mersana’s lead product candidate, XMT-1522, outside the United States and Canada The deal also expands an...

Changes to the Roche Corporate Executive Committee

Silvia Ayyoubi (62), Head of Group Human Resources for Roche and member of the Corporate Executive Committee has decided to retire from Roche following the Annual General Meeting in March 2016. Silvia Ayyoubi joined Roche in 1987 and held...

Bristol-Myers Squibb and Pfizer Sign Collaboration with Portola Pharmaceuticals to Develop and Commercialize Investigational Andexanet Alfa in Japan

Bristol-Myers Squibb Company (NYSE:BMY) and Pfizer Inc. (NSYE:PFE) today announced that the companies have entered into a collaboration agreement with Portola Pharmaceuticals Inc. (Nasdaq: PTLA) to develop and commercialize the investigational agent andexanet alfa in Japan. Andexanet alfa, which...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »